Treg-directed cancer immunotherapy beyond immune checkpoints: progress and opportunities
Trends in Pharmacological Sciences · 2026-11 · 47 (11) · 1235-1251
DOI: 10.1016/j.tips.2026.03.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2026-11. Verfasst von Jiawen Xie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioinformatics & Suzhou Municipal Key Lab of Biomedical Sciences and Translational Immunology, School of Science, Xi'an…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Neoplasms, Immunotherapy, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 117 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences and Bioinformatics & Suzhou Municipal Key Lab of Biomedical Sciences and Translational Immunology, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, China.
- Yunnan Key Laboratory of Cell Metabolism and Diseases, Center for Life Sciences, School of Life Sciences, Yunnan University, Kunming 650091, China.
- Department of Biosciences and Bioinformatics & Suzhou Municipal Key Lab of Biomedical Sciences and Translational Immunology, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, China; Biomedical Res…
Zitieren
APA
Xie, J., Hamdy, H., & Elkord, E. (2026). Treg-directed cancer immunotherapy beyond immune checkpoints: progress and opportunities. Trends in Pharmacological Sciences, 47(11), 1235-1251. https://doi.org/10.1016/j.tips.2026.03.007
Vancouver
Xie J, Hamdy H, Elkord E. Treg-directed cancer immunotherapy beyond immune checkpoints: progress and opportunities. Trends in Pharmacological Sciences. 2026;47(11):1235-1251. doi:10.1016/j.tips.2026.03.007
BibTeX
@article{Xie2026,
author = {Xie, Jiawen and Hamdy, Hayam and Elkord, Eyad},
title = {Treg-directed cancer immunotherapy beyond immune checkpoints: progress and opportunities},
journal = {Trends in Pharmacological Sciences},
year = {2026},
volume = {47},
number = {11},
pages = {1235--1251},
doi = {10.1016/j.tips.2026.03.007}
}
EUVIMED